Table 2 Characteristics of the dose-volume variables for the two subgroups (n = 264).
Variable | Variable value for patients without TLI | Variable value for patients with TLI | ||||
|---|---|---|---|---|---|---|
Mean | Minimum | Maximum | Mean | Minimum | Maximum | |
Dmax | 70.1 | 56.1 | 80.8 | 74.3 | 65.3 | 83.1 |
Mean dose | 22.7 | 6.9 | 47.2 | 27.3 | 19.1 | 37.7 |
D0.1cc | 68.3 | 54.5 | 79.1 | 72.7 | 63.9 | 82.5 |
D1cc | 64.5 | 48.1 | 77.4 | 69.9 | 58.8 | 81.1 |
D5cc | 53.3 | 28.1 | 75.9 | 62.0 | 42.9 | 77.2 |
D10cc | 43.4 | 14.6 | 74.8 | 52.9 | 32 | 73.3 |
D20cc | 32.6 | 8.2 | 71.9 | 39.8 | 24.2 | 55.3 |
TLV | 100.2 | 67 | 137.8 | 99.5 | 70.3 | 122.2 |
V75 | 0.2 | 0 | 9.0 | 1.0 | 0 | 8.4 |
V70 | 1.0 | 0 | 23.6 | 3.0 | 0 | 12.2 |
V65 | 2.3 | 0 | 30.6 | 5.1 | 0.003 | 14.9 |
V60 | 4.0 | 0 | 36.5 | 7.3 | 0.8 | 17.5 |
V50 | 8.0 | 0.8 | 48.4 | 12.2 | 3.1 | 23.2 |
V40 | 13.6 | 2.1 | 60.1 | 19.9 | 6.0 | 33.5 |
Median dose | 18.9 | 3.3 | 45.9 | 22.4 | 13.6 | 31.3 |
